DrugPatentWatch Database Preview
Details for Patent: 8,920,383
Which drugs does patent 8,920,383 protect, and when does it expire?
Patent 8,920,383 protects NORDITROPIN FLEXPRO, LEVEMIR FLEXTOUCH, NOVOLOG FLEXTOUCH, FIASP FLEXTOUCH, OZEMPIC, RYZODEG 70/30, TRESIBA, XULTOPHY 100/3.6, and SAXENDA, and is included in nine NDAs.
Protection for SAXENDA has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has ten patent family members in nine countries.
Summary for Patent: 8,920,383
| Title: | Dose mechanism for an injection device for limiting a dose setting corresponding to the amount of medicament left |
| Abstract: | A mechanism for preventing setting of a dose, which exceeds the amount of a medicament in a reservoir in an injection device. The device comprises a threaded piston rod, a limiter and a driver. The three elements are arranged such that during dose setting, the limiter is moved towards an end-of-contend position, wherein dose setting is limited. The invention comprises an accumulative and a non-accumulative embodiment. The invention further relates to a mechanism for prevention ejection of a dose exceeding the set dose. |
| Inventor(s): | Enggaard; Christian Peter (Hillerod, DK), Moller; Claus Schmidt (Fredensborg, DK), Markussen; Tom Hede (Bagsvaerd, DK) |
| Assignee: | Novo Nordisk A/S (Bagsvaerd, DK) |
| Application Number: | 11/996,409 |
|
Patent Claim Types: see list of patent claims | Use; Device; |
Drugs Protected by US Patent 8,920,383
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk Inc | NORDITROPIN FLEXPRO | somatropin | INJECTABLE;INJECTION | 021148-008 | Mar 1, 2010 | BX | RX | No | No | Start Trial | Start Trial | Y | Start Trial | |||
| Novo Nordisk Inc | NORDITROPIN FLEXPRO | somatropin | INJECTABLE;INJECTION | 021148-009 | Mar 1, 2010 | BX | RX | No | No | Start Trial | Start Trial | Y | Start Trial | |||
| Novo Nordisk Inc | NORDITROPIN FLEXPRO | somatropin | INJECTABLE;INJECTION | 021148-010 | Mar 1, 2010 | RX | No | No | Start Trial | Start Trial | Y | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,920,383
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| 05016291 | Jul 27, 2005 | |
| PCT Information | |||
| PCT Filed | July 17, 2006 | PCT Application Number: | PCT/EP2006/007004 |
| PCT Publication Date: | February 15, 2007 | PCT Publication Number: | WO2007/017052 |
International Family Members for US Patent 8,920,383
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 499962 | Start Trial | |||
| China | 101227943 | Start Trial | |||
| Germany | 602006020453 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
